Andrew Witty, CEO of UnitedHealth Group, faced bipartisan outrage from senators on the Finance Committee angered by his company's cybersecurity failures. Here were the key moments from the hearing on Wednesday.
Join our INVEST 2024 panel to explore the transformative shift in women's health investments.
Join Melissa Dennis (Partum Health), Melissa Lederer (mHUB & mHUB Ventures), Joe Connolly (Visana Health), and moderator Christiana DelloRusso (LRVHealth) to discuss this next phase in advancing women's health.
Kaiser Permanente is deploying Innovaccer's healthcare AI platform and population health management tools to support better value-based care — starting with its Washington market and potentially expanding to new markets in the future.
Mariana Oncology brings Novartis a lead radiopharmaceutical program in development for small cell lung cancer. The deal is the latest in a string of big pharma M&A moves in the red-hot radiopharmaceuticals space.
Pepper Bio has licensed rights to lerociclib, a molecule that G1 Therapeutics designed to offer dosing and safety advantages over approved therapies in the same drug class. EQRx previously held rights to the drug, but returned them after the company was acquired last year.
In this episode, we're joined by John Auerbach, senior vice president of federal health at consulting firm ICF. He discusses rising preeclampsia rates and how stakeholders need to act.
No comments